D-0014-2026 Class II Ongoing
FDA drug recall D-0014-2026 was initiated by Acella Pharmaceuticals, LLC on Sep 29, 2025 and is designated Class II. Reason for recall: Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications. The recall status is ongoing. Affected quantity: 4,680 500-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 15, 2025
- Initiation Date
- Sep 29, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,680 500-count bottles
Product description
Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.
Reason for recall
Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
Distribution pattern
Nationwide in the USA
Code information
Lot #: P24ZLK1, Exp 5/31/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0014-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026